Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Non-Opioid Pain Treatment Market From 2025 to 2029?
The market for non-opioid pain remedies has seen substantial expansion in the recent past. The size of this market is expected to increase from $50.63 billion in 2024 to $55.31 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.2%. The past growth of this market can be attributed to factors like rising instances of chronic pain, growing preference amongst patients for safer alternatives, heightened public awareness of the risks associated with opioids, an increase in demand for non-addictive treatment options, and initiatives from healthcare providers.
In the coming years, the non-opioid pain treatment market is predicted to experience substantial expansion. With a compound annual growth rate (CAGR) of 8.9%, the market is projected to reach $77.67 billion by 2029. The anticipated escalation in the coming period is ascribed to the growing demand for tailored pain management, the escalating acceptance of non-opioid therapies, the expanding senior population, increased investment in non-opioid drug innovation, and reinforced governmental support and repayment policies. Key trends for the predicted period involve enhancements in drug delivery systems, fusion of multidisciplinary care methods, the influence of technology on personalized medicine, breakthroughs in non-opioid pharmacological alternatives, and progress in patient tracking tools.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp
What Elements Are Contributing To Growth In The Non-Opioid Pain Treatment Market?
The non-opioid pain treatment market is expected to expand primarily due to a surge in sports-related injuries. Occurring during or as a result of sports or exercise activities, these injuries are increasing as more individuals participate in high-intensity sports and recreational activities. Such participation increases the likelihood of sustaining physical trauma. Non-opioid pain treatment offers a valuable solution to sports-related injuries by delivering effective pain relief and reducing inflammation, without the associated risks of opioid use. It aids in quicker recovery, enhanced functioning, and safer sustained management. For example, the 2023/24 football season saw a 4% increase in injuries, recording 4,123 cases in Europe’s top five leagues, according to the UK insurance intermediary company, Howden Group Holdings Ltd, as of October 2024. Consequently, the growth of the non-opioid pain treatment market is primarily driven by the growing prevalence of sports-related injuries.
Which Segments Are Detailed In The Global Non-Opioid Pain Treatment Market Report?
The non-opioid pain treatment market covered in this report is segmented
1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products
2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes
3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications
Subsegments:
1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products
2) By Menthol Containing: Topical Creams, Gels, Sprays
3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements
4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A
5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays
6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices
Which Emerging Trends And Strategic Shifts Are Shaping The Non-Opioid Pain Treatment Market?
Leading firms in the non-opioid pain treatment sector are channeling their resources towards the creation of innovative drug formulas, such as non-opioid oral treatments, to provide effective pain relief while mitigating risks associated with opioid usage and dependency. Non-opioid oral treatment involves pain-eliminating drugs taken orally that function through alternative modes, such as minimizing inflammation, altering nerve messages, or interacting with specific receptors to manage pain without the respiratory depression and addiction issues typically connected with opioids. For instance, Vertex Pharmaceuticals Incorporated, a biotech firm based in the U.S, launched JOURNAVX in July 2025, marking a milestone with its pioneering non-opioid therapy for moderate to severe acute pain. This advanced non-opioid treatment concentrates on modulating pain pathways and is characterized by a desirable safety profile and a swift action initiation, allowing robust pain management, decreased likelihood of dependency, and improved patient health. JOURNAVX enables targeted pain control, reduces addiction probabilities, and aides quicker recovery and superior quality of life for individuals suffering from acute pain.
Who Are The Key Contributors To Growth In The Non-Opioid Pain Treatment Market?
Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report
Which Region Is Projected To Lead The Non-Opioid Pain Treatment Market By 2025?
North America was the largest region in the non-opioid pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27366&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model